Powered by

Impel NeuroPharma Announces Appointment of Sheena K. Aurora, MD, As Vice President of Medical Affairs - Migraine Franchise; Recognized Clinician and Leader in Headache Research and Development Brings Extensive Experience in Therapeutic Advancements in Mig

Jan 16, 2020 - PR Newswire
Board and Executive Moves

PR Newswire

Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) disorders with high unmet medical needs, today announced the appointment of Sheena K. Aurora, MD, as Vice President of Medical Affairs - Migraine Franchise. Dr. Aurora will report to Dr. Stephen Shrewsbury, Chief Medical Officer, and will be responsible for leading medical affairs strategy an...